Orthofix Medical (OFIX) Common Equity (2009 - 2026)

Orthofix Medical has disclosed Common Equity across 18 years of filings, most recently posting $435.2 million for Q1 2026.

• Quarterly Common Equity fell 5.04% year-over-year to $435.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $435.2 million (down 5.04% YoY) and the FY2025 annual result came in at $450.0 million, down 10.55% from the prior year.
• Common Equity fell to $435.2 million in Q1 2026, from $450.0 million in the prior quarter.
• Over five years, Common Equity peaked at $664.2 million in Q1 2023 and troughed at $333.5 million in Q3 2022.
• A 5-year average of $485.6 million and a median of $458.3 million in 2025 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity surged 97.92% — and 2025, when it fell 19.64%.
• Tracing OFIX's Common Equity over 5 years: stood at $336.9 million in 2022, then jumped by 77.74% to $598.7 million in 2023, then declined by 15.97% to $503.1 million in 2024, then declined by 10.55% to $450.0 million in 2025, then declined by 3.3% to $435.2 million in 2026.
• Business Quant data shows OFIX's Common Equity at $435.2 million in Q1 2026, $450.0 million in Q4 2025, and $442.5 million in Q3 2025.